Nathalie Chaput

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1

Charles Ferté, Laurent Dercle, Samy Ammari, 2016, Clinical Cancer Research.

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

Olivier Lantz, Laurence Zitvogel, Clotilde Théry, 2015, Oncoimmunology.

Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα

Laurence Zitvogel, Julien Taieb, Caroline Robert, 2009, PloS one.

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

Jan Tavernier, Eric Vivier, Laurence Zitvogel, 2011, Nature Medicine.

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

Olivier Lantz, Laurence Zitvogel, Sebastian Amigorena, 2005, Journal of Translational Medicine.

Exosomes: immune properties and potential clinical implementations

Clotilde Théry, N. Chaput, C. Théry, 2011, Seminars in Immunopathology.

Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper

Andrew F. Hill, Bernd Giebel, André Görgens, 2015, Journal of extracellular vesicles.